MIGNONE ROBERTO

CIK 00012583948 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001258394

Recent Transactions

50 trades

Exercise/Conversion
Guardant Health, Inc.$GH
Restricted Stock Units
2026-01-21−264→ 8,712 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2026-01-21+264→ 3,959 total
Sale
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2025-12-16$30.24/sh−77,400→ 367,600 total
Sale
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2025-11-26$26.03/sh−50,000→ 445,000 total
Exercise/Conversion
Guardant Health, Inc.$GH
Restricted Stock Units
2025-11-21−264→ 9,240 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2025-11-21+264→ 3,431 total
Sale
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2025-11-06$24.11/sh−200,000→ 495,000 total
Exercise/Conversion
Guardant Health, Inc.$GH
Restricted Stock Units
2025-10-21−3,167→ 9,504 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2025-10-21+3,167→ 3,167 total
Award
Guardant Health, Inc.$GH
Restricted Stock Units
2025-06-18+4,203→ 4,203 total
Award
Guardant Health, Inc.$GH
Stock Option (Right to Buy)
2025-06-18+6,833→ 6,833 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2025-06-06−9,632→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2025-06-06+9,632→ 105,315 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2025-06-05+14,492→ 14,492 total
Sale
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2024-12-20$22.01/sh−286,000→ 695,000 total
Award
Guardant Health, Inc.$GH
Stock Option (Right to Buy)
2024-11-08+19,535→ 19,535 total
Award
Guardant Health, Inc.$GH
Restricted Stock Units
2024-11-08+12,671→ 12,671 total
Sale
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2024-06-18$17.03/sh−519,000→ 981,000 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2024-06-15+21,108→ 1,595,683 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2024-06-15−21,108→ 0 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2024-06-06+9,632→ 9,632 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2023-08-04−15,810→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2023-08-04+15,810→ 1,574,575 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2023-06-15+21,108→ 21,108 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2022-08-04+15,810→ 15,810 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2022-06-14−14,479→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2022-06-14+14,479→ 58,765 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2021-06-14+14,479→ 14,479 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2021-06-09+12,668→ 44,286 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2021-06-09−12,668→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2021-06-05−6,041→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2021-06-05+6,041→ 31,618 total
Purchase
Avanti Acquisition Corp.
Units, consisting of Class A ordinary share and one-half of
2020-10-01$10.00/sh+1,000,000→ 1,000,000 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2020-08-11+7,956→ 25,577 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2020-08-11−7,956→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2020-06-11−17,621→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2020-06-11+17,621→ 17,621 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2020-06-09+12,668→ 12,668 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2019-06-11+17,621→ 17,621 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2018-06-05+6,041→ 6,041 total
Purchase
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2018-05-10$19.32/sh+250,000→ 1,500,000 total
Purchase
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2018-05-09$19.21/sh+500,000→ 1,250,000 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock, $.0001 par value per share
2016-11-11$3.08/sh−322,472→ 2,968,115 total
Disposition to Issuer
RESPONSE GENETICS INC
Common Stock, $0.01 par value per share
2015-11-18−1,793,745→ 0 total
Disposition to Issuer
RESPONSE GENETICS INC
Common Stock, $0.01 par value per share
2015-11-18−2,841,255→ 0 total
Disposition to Issuer
RESPONSE GENETICS INC
Common Stock, $0.01 par value per share
2015-11-17−232,940→ 2,841,255 total
Disposition to Issuer
RESPONSE GENETICS INC
Common Stock, $0.01 par value per share
2015-11-17−147,060→ 1,793,745 total
Disposition to Issuer
RESPONSE GENETICS INC
Common Stock, $0.01 par value per share
2015-11-16−183,905→ 3,074,195 total
Disposition to Issuer
RESPONSE GENETICS INC
Common Stock, $0.01 par value per share
2015-11-16−116,095→ 1,940,805 total
Disposition to Issuer
RESPONSE GENETICS INC
Common Stock, $0.01 par value per share
2015-11-13−547,100→ 2,056,900 total

MIGNONE ROBERTO

Recent Transactions

Companies

Recent Filings

Address